Video: Ancient corn variety that makes its own nitrogen could lead to more sustainable farming

cor

In the 1980s, Howard-Yana Shapiro, now chief agricultural officer at Mars, Incorporated, was looking for new kinds of corn. He was in the Mixes District of Oaxaca in southern Mexico, the area where the precursors to maize (aka corn) first evolved, when he located some of the strangest corn ever seen. Not only was it 16 to 20 feet tall …. Yet it grew to those impressive heights in what can charitably be called poor soil, without the use of fertilizer. But the strangest part of the corn was its aerial roots–green and rose-colored, finger-like protrusions sticking out of the corn’s stalk, dripping with a clear, syrupy gel.

Shapiro suspected that …. the roots allowed this unique variety of corn, dubbed Sierra Mixe and locally bred over hundreds or even thousands of years, to produce its own nitrogen, an essential nutrient for crops ….

Now, after over a decade of field research and genetic analysis, the team has published their work in the journal PLOS Biology. If the nitrogen-fixing trait could be bred into conventional corn, allowing it to produce even a portion of its own nitrogen, it could reduce the cost of farming, reduce greenhouse gas emissions and halt one of the major pollutants in lakes, rivers and the ocean ….

Read full, original article: The Corn of the Future Is Hundreds of Years Old and Makes Its Own Mucus

Hardwired for delusion: How our brains deceive us

bookCoverhiRes
[Present bias] is the tendency people have, when considering a trade-off between two future moments, to more heavily weight the one closer to the present. A great many academic studies have shown this bias—also known as hyperbolic discounting—to be robust and persistent.

…

Present bias shows up not just in experiments, of course, but in the real world. Especially in the United States, people egregiously undersave for retirement—even when they make enough money to not spend their whole paycheck on expenses.

…

[This] is an example of cognitive bias—the collection of faulty ways of thinking that is apparently hardwired into the human brain.

…

The gambler’s fallacy makes us absolutely certain that, if a coin has landed heads up five times in a row, it’s more likely to land tails up the sixth time. In fact, the odds are still 50-50. Optimism bias leads us to consistently underestimate the costs and the duration of basically every project we undertake. Availability bias makes us think that, say, traveling by plane is more dangerous than traveling by car.

…

[W]hile present bias has so far proved intractable, employers have been able to nudge employees into contributing to retirement plans by making saving the default option; you have to actively take steps in order to not participate. That is, laziness or inertia can be more powerful than bias.

Read full, original post: The Cognitive Biases Tricking Your Brain

Viewpoint: Why we shouldn’t be deterred by CRISPR’s ‘rollercoaster year’

shutterstock e

Despite spooking investors, new insights into DNA repair and the CRISPR gene-editing system are part and parcel of its progress from research tool to human therapy.

It’s been a rollercoaster year for companies developing CRISPR gene-editing therapies. In January, a study posted on the preprint server bioRxiv raised concerns about the potential immunogenicity of CRISPR–Cas9. In March, Nature Methods retracted a study that had suggested unexpected extensive off-target mutations arising from Cas9 activity in mice. In June, two studies in Nature Medicine revealed a role for the tumor suppressor protein p53 in antagonizing Cas9 genome editing. Now a study published in our pages by Allan Bradley and colleagues reports that in addition to off-target mutations, Cas9 can sometimes induce extensive on-target DNA damage, including large deletions, inversions and insertions.

…

Many companies are already exploring solutions to these concerns. At UMass’ RNA Therapeutics meeting in May, Caribou Biosciences disclosed efforts to address off-target issues by chemical modifications and base substitutions in the guide RNA. Others are improving the specificity of Cas9 through combined rational design, directed evolution and screening for more selective variants.

…

[O]ur knowledge of CRISPR–Cas gene editing and DNA repair is progressing. The picture may not be as clear as we would like. But rarely in biology does anything turn out to be as neat and simple as we imagine.

Read full, original post: Keep calm and edit on

The next food revolution: Brought to you by CRISPR gene editing

crispr cover cmyk

Crispr has the potential to boost yields, disease resistance, and taste, and even tackle allergens like gluten. It could radically change how we breed and grow crops—and scientists say they’re working only with nature’s tools.

…

“There’s a long way to go, but what we have able to do in the last four or five years is unbelievable,” says [Zachary] Lippman, a professor of genetics at Cold Spring Harbor Laboratory. “It’s science fiction.”

…

In medicine, gene editing could potentially cure inherited diseases, such as some forms of heart disease and cancer and a rare disorder that causes vision loss. In agriculture, the technique can create plants that not only produce higher yields, like Lippman’s tomatoes, but also ones that are more nutritious and more impervious to drought and pests, traits that may help crops endure more extreme weather patterns predicted in the coming years.

…

Today hundreds of research and development labs are …. testing the potential of Crispr …. to solve a range of food-related concerns for both consumers and growers: reduced-gluten wheat that could be tolerated by those with sensitivities, a mushroom that doesn’t brown when bruised or cut, soybeans lower in unhealthy fats, and even protecting the global chocolate supply—candymaker Mars is behind an effort to bolster cacao’s ability to fight off a virus that’s devastating the crop in West Africa.

Read full, original article: Why Gene Editing Is the Next Food Revolution

Searching for the origins of the ‘dark traits’ of humanity

dark

We all know people who consistently display ethically, morally, and socially questionable behavior in everyday life. Personality psychologists refer to these characteristics among a subclinical population as “dark traits.” An understanding of dark traits have become increasingly popular not only in psychology, but also in criminology and behavioral economics.

Even though psychologists have studied various dark traits, it has become increasingly clear that these dark traits are related to each other. This raises the question: Is there a unifying theme among dark traits?

Morten Moshagen and his colleagues proposed that a D-factor exists, which they define as the basic tendency to maximize one’s own utility at the expense of others, accompanied by beliefs that serve as justifications for one’s malevolent behaviors.

…

[T]hose scoring high on the D-factor will not be motivated to increase the utility of others (helping others in need) without benefiting themselves, and will not derive utility for themselves from the utility of others (e.g., being happy for the success of others).

…

[T]hey found that all of the dark traits were substantially positively related to each other (what Spearman referred to as a “positive manifold“)– although some traits were more strongly correlated with each other than others. The strongest correlations were found among measures of Egoism, Machiavellianism, Moral Disengagement, Psychopathy, Sadism, and Spitefulness.

Read full, original post: The Dark Core of Personality

Climate change threatens champagne production, but wineries use ‘smart genetics’ to stave off problems

champagne vineyards in the montagne de reims area of the marne

In the cold, chalky cellars deep underground at boutique Champagne house A.R. Lenoble, co-owner Antoine Malassagne shares his worries about the future of the region’s world-famous fizz. Its classic style depends on …. deep, chalky soil and an until-now very cool climate.

But here’s his question: How can the taste we love stay the same in the face of climate change?

“Harvest is two weeks earlier than it was 20 years ago,” he explains …. “It used to be mid-to-late September. Now harvest often starts in August …. But maturity during hot days and nights results in lower and lower acidity in the grapes, which means less freshness in the wines.” It’s also essential to Champagne’s taste ….

…

Champagne Bruno Paillard is experimenting with covering the soil in vineyards with straw to prevent sunlight from destroying microbial life. Others are using winemaking techniques such as blocking malolactic fermentation (the second fermentation in the barrel that converts fresh-tasting malic acid to softer lactic acid) to bring greater perceived acidity to the wine.

…

Over breakfast in Reims, Thibaut Le Mailloux, the communications director of the [Comité Champagne (CIVC) trade association], outlined …. a team effort with the French National Institute for Agricultural Research to invent new hybrid grape varieties that will ripen more slowly in warmer conditions and be more resistant to pests.

Read full, original article: Is Climate Change Coming for Your Champagne?

No link found between Flores Island pygmies and ancient ‘hobbits’ in study

BB rampasasa feat

Geneticist Serena Tucci sat in the small Indonesian village of Rampasasa on Flores Island, the only woman in a room full of male researchers and pygmy villagers.

…

[O]nce the villagers understood, they were excited. They wanted to know what their genetics could reveal about their personal history. They wanted to know if they were the descendants of the ancient hominins who once inhabited their island, Homo floresiensis, sometimes called hobbits for their resemblance to the fictional Tolkien creatures.

…

The results of their research are published [August 2] in the journal Science: the modern pygmies have no relation to Homo floresiensis—though they do contain genetic material from Neanderthals and Denisovans, two extinct hominin lineages. While many modern humans have traces of extinct hominins in their DNA, the particular admixture seen in the pygmies is unique, and tells a fascinating story of how populations from different regions—the islands of Southeast Asia and the East Asia coast—mingled on this island.

…

As for how the pygmy people of Rampasasa themselves feel about the study results, that remains to be seen. In a village with no phones or Internet, sharing the data is a bit of a logistical hurdle. “We’re working now to set up a new expedition to Flores to bring the results back,” Tucci says.

Read full, original post: A New Genetic Study Suggests Modern Flores Island Pygmies and Ancient Hobbits Are Unrelated

Viewpoint: Federal regulators should clamp down on ‘misleading’ non-GMO advertising

organic

For a long time, American consumers …. could read a food label or product advertisement and trust that the information it contained was reasonably truthful.

That’s because …. the Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) were there actively to enforce laws against false and misleading marketing schemes ….

Unfortunately, that is no longer the case …. the FDA and FTC now treat one segment of the food and agriculture industry as if the laws do not apply.

That’s the $47 billion and growing organic food industry, where misleading health claims about conventional agriculture are almost universal ….

Take, for example, the seemingly ubiquitous Non-GMO Project butterfly label appearing today on more than 50 thousand products …. The Project states on its website that its purpose is to help consumers avoid “high risk” products containing GMO “contamination.”

…

[F]ood claims made on websites come under FDA’s labeling guidelines …. the assertions the Project makes on its website should be captured under FTC’s equally strict laws against misleading advertising.

The terms “high risk” and “contamination” are about as misleading as it gets …. the scientific consensus is clear: GMOs currently on the market are every bit as safe to eat as foods produced by conventional breeding.

Read full, original article: FDA and FTC need to end anti-GMO deception in organic food advertising

Could studies on gene differences lead teachers to unfairly favor ‘more educatable’ students?

book link

Educational paths are extremely varied, almost as unique as people themselves. They’re influenced by a complex slew of factors, and a recent study has introduced one more variable into the mix: genetics.

…

[T]he Social Science Genetic Association Consortium published a study identifying tiny differences between people’s DNA that are related to educational attainment, or number of years of completed schooling. Now, education researchers have to reconcile these new genetic findings with an already-complicated equation of educational success.

…

One major worry is that studies like this will be used to justify treating students unfairly based on their genes. For example, people might want to design a test to separate students based on whether they have the genetic variants.

…

[I]f certain genetic variants are associated with better educational outcomes, then there might be something about the structure of our educational system that’s favoring people with these variants.

For example, if the variants were involved in language comprehension, that could tell educators that current teaching methods aren’t working for students who process language differently. That means they should be designing new interventions to accommodate that variation.

…

“The responsibility of society is not to triage people based on genetics; it’s to provide the best possible quality of experience for everyone so they can show their true potential,” said [professor Mary Helen] Immordino-Yang.

Read full, original post: How Genetic Differences Could Make Schools Better

If every country ate like America, the world would run out of farmland, study claims

deadfarm

If everybody in the world adopted the North American diet, there would be a shortage of land …. a new study has found. The researchers, from the University of Guelph in Canada, wrote about their study in the journal PLOS ONE.

Adherence to USDA guidelines would require one giga-hectare of extra land under current farming practices, the researchers concluded. One giga-hectare is approximately the size of Canada ….

Therefore, if everybody worldwide adopted the North American diet, we would need an additional farm the size of Canada. Otherwise, we would not have enough land for our dietary requirements.

…

Global lands are a limited resource. Therefore, there should be international coordination of dietary guidelines, the authors suggested.

Prof. Madhur Anand, director of the Global Ecological Change and Sustainability lab, said:

“This could be similar, at least in principle, to how greenhouse gas emissions are increasingly being coordinated internationally to address another major global problem: climate change.”

Read full, original article: North American diet is unsustainable

Boy almost back to normal 3 years after doctors remove large section of his brain

DjcaUB WwAEUfna

A boy who had large parts of the right side of his brain removed due to a slow-growing tumor made a nearly full recovery in the three years after his surgery, with other areas of his brain compensating for the loss.

Their case study highlights the brain’s tremendous ability to adapt to such losses and will help researchers better understand how, exactly, parts of the brain can accommodate such losses, the researchers write.

The boy, identified as UD in the case study, was a healthy, normal kid—up until he suddenly suffered a seizure at age four. He subsequently developed intractable epilepsy due to the tumor. When he was nearly seven years old, his parents and doctors made the tough decision to surgically remove the mass. That also meant removing the entire right side of his occipital lobe and part of his temporal lobe on his right side.

…

After the surgery, doctors and researchers weren’t sure exactly how UD’s brain would handle losing such key visual and recognition regions.

…

“The dramatic findings of essentially normal perceptual behavior and normal (albeit rearranged) neural correlates… attest to the power of plasticity of the higher-order visual system,” [researcher Marlene] Behrmann and colleagues conclude.

…

[T]he surgery and reorganization was a triumph for UD—who has also been seizure free since the procedure.

Read full, original post: Doctors cut out a large chunk of a boy’s brain—now he’s doing just fine

Are Roundup-cancer lawsuits about profit, politics or public health?

Monsanto Money Crops

You might think that the popular weed killer known as Roundup is causing cancers around the world thanks to alarming news coverage of pending lawsuits. The first of thousands of such cases has now gone to trial in San Francisco, with the [jury finding for the plaintiff] that Roundup caused his non-Hodgkins lymphoma.

But don’t panic…it is highly unlikely that they have anything to do with glyphosate, which is the active ingredient in Roundup. Rather, opportunistic trial lawyers have latched onto claims about cancer risks, hoping that Monsanto, glyphosate’s manufacturer, will pay them to go away in generous legal settlements.

…

The International Agency for Research on Cancer decision in 2015 to classify glyphosate as “probably carcinogenic” triggered the trial lawyers’ interest in the chemical and also prompted some nations and a number of local governments to ban the product.

Yet IARC’s classification is contradicted by …. evaluations by U.S. Environmental Protection Agency…the European Food Safety Authority (2015), Health Canada (2017), the UN Food and Agriculture Organization (2016), and others.

…

So, as the headlines about Roundup trickle out, don’t worry if you’ve used or want to use the weed killer again. These cases actually have little to nothing to do [with] the risk and everything to do [with] trial lawyers using junk science to cash in on other people’s suffering.

Read full, original article: GUEST COMMENTARY: Is your weed killer killing you?

Celiac disease: What’s behind the surge in diagnoses?

celiac
A few years ago, the book “Wheat Belly” became a hit, as it pointed to new “scientifically engineered” strains of wheat as the cause of a range of disorders from diabetes to obesity to gluten intolerance and celiac disease. The book’s author, William Davis, appeared on shows like “Dr. Oz,” and the meme urging everyone to avoid whole grains roared across the internet.

But the claim of new and dangerous wheat strains wasn’t true. It took a University of Saskatchewan researcher and his team to compare existing wheat strains and show that they’re exactly the same ones our ancestors ate more than 100 years ago.

Another claim that turned out false was proposed around the same time by Anthony Samsel and Stephanie Seneff, the first an independent scientist and consultant, and Seneff a computer science professor at MIT. The researchers — known for their celiacopposition to genetically modified crops and glyphosate that’s often paired with them — argued in a paper that the herbicide is the “most important causal factor in this epidemic. Fish exposed to glyphosate develop digestive problems that are reminiscent of celiac disease.”

Subsequent reports have debunked the duo’s conclusions, finding, as one group from Guy’s Hospital in London phrased it in Frontiers in Public Health, “these authors inappropriately employ a deductive reasoning approach based on syllogism.”

But what is true is that cases of both celiac disease and intolerance to gluten are apparently growing like healthy spring wheat. Why? The cause might be an increase in whole wheat in our diets, but it also could be other things, including changes in diagnoses, genetics and exposure to antigens. And a lot of gluten avoidance may be nothing more than a current fad. For patients, scientists and physicians, the most important question is: how do we parse this out?

First, here’s a good overview of celiac disease and gluten:

[youtube https://www.youtube.com/watch?v=nXzBApAx5lY&w=600&h=400]

 

Celiac disease itself is an autoimmune disorder, with markers consisting of mutations in genes that control the expression of HLA-DQ, a receptor on antigen-presenting cells that distinguishes “self” from “not self,” thereby controlling T cell activity against foreign bodies. However, only 40 percent of people who carry one of these two mutations actual get celiac disease.

This genetic mutation has led to larger estimates of how much of the population is susceptible to celiac. In 2017, Edwin Liu, a gastroenterology researcher at Children’s Hospital Colorado in Denver, tracked the mutations in more than 1,300 newborns and found that the prevalence of mutations was about three percent, three times the general assumption of one percent. Another study, conducted in Sweden, also arrived at the three percent.

This three percent figure doesn’t include a another new and growing disease category—people who have no sign of celiac disease who nonetheless show hypersensitivity to gluten. They’re now classified as a vague illness called nonceliac gluten sensitivity (NCGS), marked by the same abdominal pain, bloating, diarrhea, headaches, fatigue, rashes and joint that that’s seen in celiac disease, but without the genetic and physiological markers seen in celiac. But they may end up rounding out the definition of what happens when you’re exposed to gluten—and things don’t go well.

celiac 6 7 18 3

One suspected group of chemicals is known as FODMAPs—fermentable oligosaccharides, disaccharides, monosaccharides and polyols—that are poorly digested but present in wheat, fruits and other foods. Some researchers, including University of Oslo gastroenterologist Knut Lundin, believe that a specific immune reaction to gluten and its protein component, gliadin, is the reason for these disorders.

Another problem with these diseases is that they are often assembled as a spectrum or range of disorders. And the “spectrum diagnosis” raises red flags with some researchers. An additional issue is that true reactions are hard to measure from people’s dietary habits, because many people (including fad dieters and opportunistic consultants) are avoiding gluten, creating a blurry picture of the disease. Rutgers University scientist Hyun-seok Kim and colleagues noted that celiac diagnoses have been stable since about 2009, but the number of people switching to gluten-free diets have shot up much faster than actual celiac diagnoses.

Armin Alaedini is an immunologist at Columbia University and has garnered something of a reputation for chasing spectrum disorders. Alaedini has studied several spectrums, including a debunking of an alleged link between Lyme disease and children with autism. In NCGS, he suspected another spectrum that might consist more of public misunderstanding than of a true disease.

He first began searching for true biomarkers, like the genetic and immune anomalies that appear in celiac disease. This would mark an improvement over current research on NCGS, in which patients simply tell a doctor how they feel before and after eating gluten.

Looking at 80 blood samples from Italian patients who claimed to be gluten sensitive, Alaedini looked for antibodies or other immune signals. He found them. NCGS patients had higher levels of antibodies that reacted to gluten in ways that didn’t occur in celiac and healthy people. Two other proteins that indicated an inflammatory response to bacteria were also elevated only in these patients.

Work by Alaedini and Lundin will take a while but takes a more scientific approach to what may end up not so much a spectrum, but a mosaic of different digestive diseases with similar symptoms, but different causes. And a number of people who prefer a gluten-free diet probably have neither celiac disease nor gluten sensitivity, but that number will be very difficult to pin down. Probably not the stuff of “Dr. Oz.”

Andrew Porterfield is a writer and editor, and has worked with numerous academic institutions, companies and non-profits in the life sciences. BIO. Follow him on Twitter @AMPorterfield.

5 ways the USDA could resolve challenges surrounding ‘bioengineered’ food labels

label
Two years ago, President Obama signed the National Bioengineered Food Disclosure Law (NBFDL) into law, requiring food manufacturers to disclose the presence of bioengineered foods and ingredients. That law required the U.S. Department of Agriculture to finalize regulations for the law’s implementation by its two-year anniversary; that deadline passed quietly on July 29, 2018 without any final regulation.

But the agency has at least been somewhat active. On May 4th, USDA did propose regulations, and it received more than 14,000 comments from the public (including a written submission by CSPI) before the July 3rd comment period deadline. Now, the USDA needs to go through those comments, consider them, and finalize its regulations—a process that will take at least several months. In the interim, it is worth identifying some of the important decisions the USDA must make, discussing different positions on those issues, providing CSPI’s take on those issues, and predicting how the USDA might resolve them. In so doing, it is important keep in mind the sage words of the Nobel Prize-winning physicist, Nils Bohr: “Prediction is very difficult, especially if it’s about the future.”

Background on the NBFDL

Under the NBFDL, a food manufacturer can choose among three different options to disclose foods or ingredients that are bioengineered:

  •  Use text on the product’s package, as specified by the USDA;
  •  Include a symbol, which will be developed by the USDA, on the package; or
  •  Add an electronic or digital link (such as a QR code, bar code, or SmartLabel) on the package.

label 8 9 18 2

The NBFDL defines “bioengineering” to mean any food “(a) that contains genetic material that has been modified through in vitro recombinant DNA techniques; and (b) for which the modification could not otherwise be obtained through conventional breeding or not found in nature.” It also identifies exemptions from the disclosure requirements, such as food served in restaurants or similar establishments and food products from “very small food manufacturers.” As with any law, the devil is in the details. That’s why the USDA regulations are so important.

Issue 1: What Term to Use:  Bioengineered, Genetically Engineered, Genetically Modified, and/or GMO?

What term should be used to describe a product or ingredient that was produced from a bioengineered organism? In the NBFDL, Congress used “bioengineered,” but it gave the USDA the discretion to allow other “similar” terms. In its proposed rule, the USDA stated that it considered alternative phrases, but ultimately sided with only using “bioengineered.” That decision is supported by trade associations representing different parts of the food industry (e.g., the Grocery Manufacturers Association, Food Marketing Institute, American Soybean Association, and American Farm Bureau Federation).

Many organizations and food companies (including organic ones) are urging the USDA to allow the use of other terms, specifically “genetically engineered,” “genetically modified,” and/or “GMO.” Some (Campbell Soup, for example) argue that “GMO” is the most familiar and preferred term for consumers. Others (including Stonyfield) argue that there should be consistency among government programs and that “GMO” is used in the USDA’s National Organic Standards Program. Still others (like the Environmental Working Group) argued that “bioengineering” is a term associated with the medical field, not food. At the same time, some comments pointed out that all crops have been “genetically modified” from their ancestors or that “GMO” can be misinterpreted by consumers who think that a live “organism” is part of the food.

label 8 9 18 3
The Campbell Soup Company’s GMO label.

CSPI’s Position: Disclosures should only be allowed to use “genetically engineered” or “bioengineered” since both are scientifically accurate terms and the FDA uses both of those terms in its voluntary labeling guidance.

Predictions:

  • 60% chance that the USDA will allow “genetically engineered.”
  • 40% chance that the USDA will allow “genetically modified” or “GMO.”

Issue 2: What Symbol to Use

The NBFDL gives food manufacturers the option of disclosing bioengineered foods using a symbol instead of text on the package. The USDA proposed three options for the public to comment on:

 

label 8 9 18 4As expected, reactions varied tremendously. A coalition of a large majority of the food industry preferred the first symbol. But, many commenters disliked all three symbols because they portrayed GMOs in too positive a light. Some described the second and third as a “smiling sun” and a “winking face.”

The USDA’s proposal also asked the public whether the symbols should incorporate the word “bioengineered” in addition to just the letters “BE.” In a poll by the International Food Information Council, only 23% of consumers said that felt that the symbol alone was the right amount of information, but when “bioengineered” was added to the symbol, 65% of consumers thought the symbol now had the right amount of information.

CSPI’s Position:  USDA should require use of a neutral symbol. While none of the proposed symbols are neutral, the first alternative is the best of the ones proposed.

Predictions: 

  • Less than 20% chance that the USDA will significantly change the proposed symbols (such as eliminating the smile) or develop a new symbol.
  • A toss-up which symbol the USDA will pick, though the first has a slight advantage.
  • 80% chance the USDA will allow inclusion of the word “bioengineered.”

Issue 3: Whether to include Highly Refined Ingredients and Products

Probably the most controversial issue is whether highly refined ingredients, such as sugar or corn oil, should require disclosure. Highly refined ingredients produced from an engineered crop don’t contain any bioengineered content (DNA or protein) and are biologically and chemically identical to the same ingredient made from a non-bioengineered crop. The stakes are high. Different stakeholders have estimated that anywhere from 18% to 78% fewer food products would be disclosed if highly refined ingredients derived from a bioengineered crop are not included. Those analyses are contrary to USDA’s finding that exempting highly refined ingredients would have little impact on the number of products that would require disclosure.

Mis- and disinformation are distorting science and public policy. Subscribe to our Daily and Weekly Digests for incisive coverage of ‘disruptive’ innovations in AI, agricultural biotechnology, food, chemicals, nuclear energy, vaccines, and other disruptive innovations.

The USDA proposed two options, probably because the food industry is divided. The first option, which is supported by farmers and developers of genetically engineered seeds, is that highly refined ingredients should not be disclosed. Those groups argue that highly refined ingredients are not “bioengineered” because there is strong scientific evidence that they don’t have any measurable DNA or protein. Some countries with mandatory GMO labeling, including Thailand, Japan, New Zealand, Australia, and Indonesia, exempt highly refined ingredients for that reason.

The second option is that highly refined ingredients should be disclosed. That position is supported by many consumer and environmental groups, members of the organic industry, food companies, and food retailers. They make several different arguments, including:

  • There is scientific evidence that highly refined ingredients do contain genetic material, even if it is not readily detectible;
  • Members of Congress, during debate, stated that the statute was meant to cover highly refined ingredients and to cover more products than the state laws the statute replaces (which all included those ingredients);
  • Consumers expect to know if an ingredient came from a bioengineered crop even if it is highly refined, and they are interested in information about how the crop was grown.
  • To be transparent, many food companies will disclose highly refined ingredients voluntarily, which could lead to consumer confusion if the disclosures aren’t required for all products;
  • The inclusion of highly refined ingredients will be less disruptive, since at least 38 countries require mandatory labeling of those ingredients, including major trading partners like the European Union, the United Kingdom, and Brazil.
label 8 9 18 5.png

CSPI Position:   The disclosure should Include highly refined ingredients, but the USDA should require disclosure language which says these ingredients are “derived from bioengineered crops but does not contain bioengineered materials.”

Prediction:  80% chance that the USDA will require disclosure for highly refined ingredients, but without different language.

Issue 4: Whether to Include Gene-Edited Agricultural Products

Should only traditional genetically engineered organisms (i.e., where a foreign gene has been added) be disclosed, or should disclosure also include products that contain ingredients produced through newer gene-editing techniques (i.e., using techniques such as CRISPR, where DNA changes can be made within a species without adding foreign DNA)? The question arises because two terms in the definition of “bioengineered” need clarification—“conventional breeding” and “found in nature”. How those terms are defined will determine which breeding techniques trigger disclosure.

The food industry is mostly united in the position that gene-edited products should not require disclosure. They argue that “conventional breeding” should be defined as methods that take advantage of the existing potential genetic variability of an organism. If a gene-edited product could have been produced through conventional breeding, such as chemical mutagenesis, then it should not be subject to disclosure. Similarly, “found in nature” should be broadly defined to include all types of genetic modification—such as deletions, insertions, substitutions, and duplications—if they are within the organism’s own genome (i.e., no foreign DNA in the product).

On the other hand, many consumer and environmental groups, and some members of the food industry (those primarily involved with organic products), have asked the USDA to include gene-edited products. They rely on statements by Sen. Debbie Stabenow (the ranking member of the Senate Agriculture Committee) that the law was meant to include gene-edited products, as well as a letter that the USDA’s general counsel wrote when the law was passed that said the USDA has legal authority to include gene-edited products. They argue that defining “bioengineering” broadly is consistent with international agreements whose definitions of GMOs would capture gene-edited products. They also argue that the definitions of “conventional breeding” and “found in nature” should be narrow, as is the “classical/traditional plant breeding” definition from the National Standards Organic Board.

CSPI Position: We did not take a position on this issue.

Prediction:  Less than 15% chance that the USDA will include gene-editing.

Issue 5: When Disclosure will Occur

According to the proposed rule, food manufacturers must disclose the presence of bioengineered foods and ingredients by January 1, 2020, which is the date by which foods must carry the updated Nutrition Facts label. If the final regulations had been issued on July 29, 2018, food manufacturers would have had 17 months to implement the NBFDL.

As expected, commenters provided a spectrum of views. Those who want an all-encompassing disclosure rule also want food manufacturers to comply no later than the USDA’s proposed date. But, many food manufacturers asked for more time. For example, Danone and the Food Marketing Institute asked for 24 months from the publication of the final rule, while Walmart asked for three years.

Regardless of the compliance date, it will take a significant amount of time for the USDA to review the comments, address the issues, and finalize the regulations. In addition to the big-ticket items discussed above, there are dozens of details that are essential to a regulation that provides uniform information to consumers.

CSPI’s Position: We did not take a position on this issue.

Prediction:

  • 100% chance that the USDA will delay the compliance date.
  • 80% chance that the USDA will provide at least 24 months after the final rule’s publication.

We’re newcomers to the world of predictions, so don’t bet the house on these. It’s probably best to heed Lao Tzu on this matter: “Those who have knowledge, don’t predict. Those who predict, don’t have knowledge.”

Gregory Jaffe is the director of the Project on Biotechnology at the Center for Science in the Public Interest. Follow him on Twitter @JaffeGregory.

This article was originally published at the Center for Science in the Public Interest as Forecasting the USDA’s Final Bioengineered Disclosure Rule and has been republished here with permission.

Biotech startups race against ‘Big Ag’ to develop gene-edited crops

Calyxt Inc, an eight-year-old firm co-founded by a genetics professor, altered the genes of a soybean plant to produce healthier oil using the cutting-edge editing technique ….

Seventy-eight farmers planted those soybeans this spring across 17,000 acres in South Dakota and Minnesota, a crop expected to be the first gene-edited crop to sell commercially, beating out Fortune 500 companies.

Seed development giants such as Monsanto, Syngenta AG and DowDuPont Inc have dominated genetically modified crop technology that emerged in the 1990s. But they face a wider field of competition from start-ups and other smaller competitors because gene-edited crops have drastically lower development costs and the U.S. Department of Agriculture (USDA) has decided not to regulate them.

Relatively unknown firms including Calyxt, Cibus, and Benson Hill Biosystems are already advancing their own gene-edited projects in a race against Big Ag for dominance of the potentially transformational technology.

…

The newly competitive landscape could foster more partnerships and licensing deals between big and small firms, along with universities or other public research institutions, said Monsanto spokeswoman Camille Lynne Scott. Monsanto – which was recently acquired by Bayer AG – invested $100 million in startup Pairwise Plants this year to accelerate development of gene-edited plants.

Read full, original article: Gene-editing startups ignite the next ‘Frankenfood’ fight

Does popular antipsychotic drug Abilify cause ‘uncontrollable urges’ to gamble, eat and have sex?

clearwater abilify compulsive gambling

By the time she stopped taking aripiprazole — an antipsychotic sold under the brand name Abilify — [Denise Miley had] stayed in the casino long enough to lose more than $150,000. Miley, 41, filed a lawsuit in January 2016 against the drug makers Bristol-Myers Squibb and Otsuka, alleging the drug — one of the best-selling in the world — caused compulsive behavior.

…

Hundreds more people have since sued the companies, claiming that the drug caused them to gamble, eat, or have sex compulsively. And the Food and Drug Administration signaled its own concern in a 2016 safety warning, saying that uncontrollable urges to gamble, binge eat, shop, and have sex had been reported with use of the antipsychotic.

…

The lawsuits are the latest chapter in the roller-coaster history of Abilify. It was approved by the FDA for schizophrenia in 2002. It’s since been approved for treating bipolar disorder, irritability associated with autistic disorder, Tourette’s syndrome, and major depressive disorder.

…

The science on the potential link between Abilify and impulse control problems is far from settled.

…

Experts say the more critical question — and the bigger mystery — is why impulse-control problems might show up in just a small slice of the millions of patients who take Abilify each year.

Read full, original post: Did a blockbuster drug make hundreds gamble compulsively? A legal fight may decide what science can’t confirm

Could studying rare Parkinson’s mutation help treat other cases?

http F Fi huffpost com Fgen F Fimages Fn PARKINSONS DISEASE x

A handful of gene mutations are linked to inherited PD, but they account for less than 15 percent of the one million U.S. cases and the five million worldwide. The most common of these is a mutated version of leucine-rich repeat kinase 2 (LRRK2).

…

LRRK2 has drawn the interest of pharmaceutical companies because it is an accessible drug target. The gene encodes a namesake protein that functions as a type of enzyme called a kinase. The LRRK2 protein attaches chemical tags called phosphates to other proteins. Like a molecular switch, these phosphate tags activate or silence LRRK2’s targets.

…

[However, the] LRRK2 protein, which helps break down large molecules in the cell, might also play a role in nongenetic forms of the disease. A study published July 25 in Science Translational Medicine suggests LRRK2 might indeed be a culprit in a much broader population of PD patients.

…

The findings suggest many paths could lead to LRRK2 overactivity and subsequently to PD pathology. The implication: a drug roadblock of LRRK2 might halt progression of PD in people with and without the mutation.

…

Instead of developing a drug for perhaps 5 percent of the PD patient population, [Todd Sherer] says, “these data suggesting that LRRK2 plays a role in perhaps the other 95 percent…could mean a broader impact across the board.”

Read full, original post: Parkinson’s Drugs Aimed at Rare Gene Mutation Show Promise for Other Sufferers, Too

European farmers already pondering what life without glyphosate might be like

roundup

In the aftermath of the European Parliament’s 355-204 vote opposing the renewal of the popular herbicide glyphosate in 2018 for households and after 2022 for agriculture, farmers, policymakers and activists have begun the search for viable alternatives to the agricultural chemical. And they aren’t finding much.

Although the vote is not a direct ban (instead, it showed no MEP support for a renewal), it was cast in opposition to the European Commission’s proposal to extend glyphosate’s license for 10 years, and provided political gravitas to Green party and other anti-pesticide members of both the European and member nation parliaments, who have advocated against the chemical’s use for years. In the US, glyphosate is popular because it is used with genetically modified crops (“Roundup-ready”) that can grow despite applications of the herbicide. In Europe, where such GMO crops have never been approved, opposing groups have tried to link glyphosate to health issues instead of directly agricultural ones.

Most of the health claims have arisen from a monograph from the International Agency for Research on Cancer (IARC), the World Health Organization’s cancer research arm, which stated that glyphosate could “probably” cause cancer. As has been written before, IARC’s methodology of evaluating hazards and not risks, its selective inclusion of scientific papers, and – most recently – allegations of result cherry picking and conflicts among its lead consultants and researchers all have increased skepticism of IARC’s conclusion. However, among environmental groups and certain MEPs, health concerns prevail.

And other concerns have moved from the dubious to the downright bizarre. Alison Van Eenennaam, an animal geneticist at the University of California, Davis, observed that these claims now include:

Decreasing dopamine and serotonin leading to tiredness and anger; shutting down the cytochrome P450 detox pathway, leading to the accumulation of “toxins;” glyphosate crossing the blood-brain barrier for some reason; and especially in conjunction with lead and mercury, that glyphosate is an endocrine disrupting chemical which is more dangerous at lower doses than at higher doses. They also claimed that it kills beneficial bacteria, but not the bad nasty bacteria, and this supposedly leads to a long list of disorders, including poor sex drive and infertility. They went on to claim that it stops mitochondria from making energy and this creates brain fog and is linked to birth defects and destruction of endocrine systems, and also non-alcoholic fatty acid disease. Then there was the assertion that the extracellular matrix which communicates information body-wide gets “crushed” by glyphosate, and finally that glyphosate is a highly toxic and long-lasting organophosphate.

Organophosphate, of course, is a completely different—and non-transformable—chemical.

Nonetheless, according to the MEPs voting against glyphosate, there exist “biological alternatives (i.e. “integrated pest management systems”) (that) work well for weed control.”

Ask farmers and scientists, however, and you’ll hear a different story.

For years now, European farmers have been using IPM, in addition to having glyphosate around. Under European Commission Directive 2009/128/EC, member states were since 2012 required to promote IPM techniques, which include prohibitions on aerial spraying, limitations on pesticide use “in sensitive areas,” inspection of application equipment, and training.

Some groups, like the Natural History Museum of Cleveland, reviewed other IPM chemicals for their herbicidal properties and found shortcomings among all of them:

  • Acetic acid—aka vinegar, will burn the leaves of weeds. It will also burn the leaves of crop plants.
  • Fatty acids—usually part of pesticide soaps, these chemicals also will burn the leaves of weeds (and crop plants), and don’t last very long, opening the window to weed re-infestation.
  • Essential oils–clove, peppermint, pine, and citronella also act to burn plant leaves, and many do not work well because they evaporate or are chemically inactivated before they contact a plant.
  • Corn gluten—can prevent fledgling weeds from arising, but only works on a small (think garden) plot and doesn’t work at all against established, mature weeds.

Meanwhile, the President of the French Grain Producers’ Organization wrote Vytenis Andriukaitis, European Commissioner responsible for glyphosate issues, in October, claiming that:

I will suffer significant damage, including a significant increase in my production costs (use of larger amounts with other herbicides and increase in the frequency of herbicide treatments), dirtying of my plots with many weed species, including perennials. My working methods should evolve with a return to plowing, the removal of new simplified farming techniques, based on plant cover. I could not practice agroecology anymore.

Other commercial herbicides exist to replace glyphosate, of course. But, like Syngenta’s Reglone and Bayer’s Basta S, they are much more expensive than glyphosate. Also, Reglone is a crop desiccant, quickly burning leaves upon contact, while glyphosate is a more systemic herbicide. Basta S does not translocate between plants and requires 100 spray coverage to be effective, while glyphosate does not require these applications.

Another pesticide, atrazine, is available and popular in the United States but has been banned by the European Union for at least 10 years. The EU banned its use not because of health issues, but because of its persistence in aqueous environments. In the US, groups like the Natural Resources Defense Council claimed that it is an endocrine disruptor, and linked it to cancer, developmental issues and other medical problems.

Many European farmers will continue to use combinations of several agricultural chemicals and IPM methods to control weeds. “Where glyphosate is commonly used in the EU is in no-till conservation agriculture and complex multiple cover cropping,” said David Zaruk, risk communications specialist, EU politics observer and author of the “Risk Monger” blog. “Alternatives are not clear or have harsher effects on the soil.”

Urban gardeners will also be forced to settle for less effective alternatives. As the University of Florida Extension pointed out, because organic (and even conventional) chemical alternatives don’t share glyphosate’s systemic properties, they will only work on contact and won’t be as effective on larger weeds. Hence, more applications, more money, more environmental impact.

Andrew Porterfield is a writer and editor, and has worked with numerous academic institutions, companies and non-profits in the life sciences. BIO. Follow him on Twitter @AMPorterfield.

Editor’s note: This article originally ran at the Genetic Literacy Project as European farmers: Finding replacement for glyphosate is no easy task on November 14, 2017.

Does glyphosate cause cancer? Jury says says ‘yes’ but years of research show the herbicide is safe

Can anyone make sense of the debate over glyphosate, the active molecule in the most widely used herbicide [Roundup] in the world?

[On August 10, a California jury awarded $289 million to a former school groundskeeper who said Monsanto’s Roundup left him dying of cancer. This article appeared in January, 2018.]

…

At the heart of the problem is the messy fact that when scientists and policymakers carelessly substitute risk for hazard, flawed conclusions are drawn.

….

This is an important factor to consider with regards to the glyphosate debate. When IARC announced in June 2015 that glyphosate was “probably carcinogenic” to humans, Kate Guyton, a toxicologist and lead author of the IARC monograph, stated that “because the evidence in laboratory animals was sufficient and the evidence in humans was limited, this places [glyphosate] in Group 2A [of probable carcinogens].” It was later revealed that IARC scientists had removed findings from studies that concluded glyphosate to be noncarcinogenic before publishing the final version. The edits were made in the monograph’s chapter on animal studies, which crucially informed IARC’s assessment that glyphosate causes cancer.

…

[A] long-term observational analysis of the health effects of herbicides on 89,000 farmers and their families in Iowa and North Carolina …. Running since 1993…. has consistently failed to find that glyphosate use is linked with increased risk of cancer.

…

These findings have been backed up by other studies as well. Last year, the U.N.’s Food and Agriculture Organization and the World Health Organization presented a joint review report on pesticide residue in indirectly exposed persons, including farming and production workers’ families, as well as consumers. The report did not find any evidence of increased risk of cancer from glyphosate exposure.

…

In this case because of the absence of evidence against glyphosate, we should be aware of the potential for hazard, but the chemical should be considered noncarcinogenic. Otherwise, the purpose of science itself, which will always entail some degree of uncertainty, is utterly undermined.

Read full, original article: How Do You Assess if a Chemical Causes Cancer?